Narrow search
Showing 1 - 10 of 523
Cover Image
Heterogeneous Distributions of Firms Sustained by Innovation Dynamics – a model with an empirical application
Andersson, Martin; Johansson, Börje - Centre of Excellence for Science and Innovation … - 2010
exit of products and firms associated with it. It is based on a model where new products are introduced by innovating firms … pattern (varieties and markets) of existing firms in combination with entry/exit of firms. The empirical results are … subtract varieties from their product mix, and new firms may enter while some exit. Third, an econometric analysis where firms …
Persistent link: https://www.econbiz.de/10008626064
Cover Image
Quadratic Costs, Innovation and Welfare: The Role of Technology
Marjit, Sugata; Mishra, Suryaprakash - 2020
that if the technology is already advanced and competition intensifies then firms wouldn’t innovate. The dynamic … interaction we attempt to capture and explain is the one of technology with the possibility of innovation via the intensity of …
Persistent link: https://www.econbiz.de/10012269594
Cover Image
Quadratic costs, innovation and welfare : the role of technology
Marjit, Sugata; Mishra, Suryaprakash - 2020
that if the technology is already advanced and competition intensifies then firms wouldn’t innovate. The dynamic … interaction we attempt to capture and explain is the one of technology with the possibility of innovation via the intensity of …
Persistent link: https://www.econbiz.de/10012263851
Cover Image
Stimulating Innovation in Russia: The Role of Institutions and Policies
Gianella, Christian; Tompson, William - Economics Department, Organisation de Coopération et … - 2007
This paper examines the potential role of innovation policy in enhancing long-term productivity growth in Russia. It begins by exploring the role of framework conditions for business in encouraging innovative activities, particularly with respect to intellectual property rights and competition....
Persistent link: https://www.econbiz.de/10005046124
Cover Image
Chapter Twelve. Markets for Pharmaceutical Products
Scott Morton, Fiona; Kyle, Margaret - In: Handbook of health economics : volume 2, (pp. 763-823). 2011
This chapter describes the market for pharmaceuticals, which exceeded $500 million in sales in 2010. The industry is also characterized by extensive regulation of almost every activity, from product development through manufacturing and marketing, which we summarize. We next describe the...
Persistent link: https://www.econbiz.de/10014025576
Cover Image
R&D IN THE PHARMACEUTICAL INDUSTRY: A WORLD OF SMALL INNOVATION
Dominguez, Beatriz; Ganuza, Juan-José; Llobet, Gerard - Centro de Estudios Monetarios y Financieros (CEMFI) - 2006
It is commonly argued that in recent years pharmaceutical companies have directed their R&D towards small improvements of existing compounds instead of more risky drastic innovations. In this paper we show that the proliferation of these small innovations is likely to be linked to the lack of...
Persistent link: https://www.econbiz.de/10005827081
Cover Image
R&D in the pharmaceutical industry: A world of small innovations
Domínguez, Beatriz; Ganuza, Juan José; Llobet, Gerard - Department of Economics and Business, Universitat … - 2005
It is commonly argued that in recent years pharmaceutical companies have directed their R&D towards small improvements of existing compounds instead of more risky drastic innovations. In this paper we show that the proliferation of these small innovations is likely to be linked to the lack of...
Persistent link: https://www.econbiz.de/10005772335
Cover Image
Titanium Implants – A Comparison of a Swedish and an Ohio Firm
Fridh, Ann-Charlotte - Ratioinstitutet - 2003
, technology and customers. But the diffusion occurred in two different (institutional) environments, the Swedish and the US. The …
Persistent link: https://www.econbiz.de/10005190444
Cover Image
Pharmaceutical industry, drug quality and regulation. Evidence from US and Italy
Atella, Vincenzo; Bhattacharya, Jay; Carbonari, Lorenzo - Centro di Studi Internazionali Sull'Economia e la … - 2008
The aim of this article is to analyze the relationship between drug price and drug quality and how it varies across two of the most common regulatory regimes in the pharmaceutical market: Minimum Efficacy Standards (MES) and Price Controls (PC). We develop a model of adverse selection where a...
Persistent link: https://www.econbiz.de/10005694983
Cover Image
Investments in Pharmaceuticals Before and After TRIPS
Kyle, Margaret K; McGahan, Anita M - C.E.P.R. Discussion Papers - 2011
This paper addresses the relationship between patent protection and investment in the development of new pharmaceutical treatments. The TRIPS Agreement, which specifies minimum levels of intellectual property protection for countries in the World Trade Organization, has increased levels of...
Persistent link: https://www.econbiz.de/10009002387